What Researchers Did
The clinical and dental records of 26 patients with postradiation osteonecrosis (PRON) managed with hyperbaric oxygen (HBO) were reviewed to determine the efficacy of HBO.
What They Found
Eighteen of 26 patients achieved persistent mucosal and cutaneous coverage, with a median follow-up of 24 months after the first HBO session. Overall, 21 of 26 patients showed improved PRON status, and 13 of 26 met strict criteria for disease resolution following HBO therapy.
What This Means for Canadian Patients
For Canadian patients experiencing postradiation osteonecrosis, hyperbaric oxygen therapy, as part of a comprehensive treatment plan, may offer a safe and effective option for managing their condition. This could lead to improved healing and resolution of symptoms, enhancing their quality of life after radiation treatment.
Canadian Relevance
This study has direct Canadian relevance as it was conducted by Canadian researchers, contributing to the understanding and management of postradiation osteonecrosis within the Canadian healthcare system.
Study Limitations
As a retrospective review of a small cohort of 26 patients, this study's findings may have limited generalizability and are subject to inherent biases.